ID16921A - Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 - Google Patents

Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Info

Publication number
ID16921A
ID16921A IDP971640A ID971640A ID16921A ID 16921 A ID16921 A ID 16921A ID P971640 A IDP971640 A ID P971640A ID 971640 A ID971640 A ID 971640A ID 16921 A ID16921 A ID 16921A
Authority
ID
Indonesia
Prior art keywords
cycloxigenase
composition
diseases related
against diseases
day treatment
Prior art date
Application number
IDP971640A
Other languages
English (en)
Indonesian (id)
Inventor
Bruno Hancock
Conrad Winters
Barry Gertz
Elliot Ehrich
Original Assignee
Merck & Co Inc
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16921(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612063.9A external-priority patent/GB9612063D0/en
Application filed by Merck & Co Inc, Merck Frosst Canada Inc filed Critical Merck & Co Inc
Publication of ID16921A publication Critical patent/ID16921A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP971640A 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 ID16921A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1787896P 1996-05-17 1996-05-17
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (1)

Publication Number Publication Date
ID16921A true ID16921A (id) 1997-11-20

Family

ID=26309472

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971640A ID16921A (id) 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Country Status (29)

Country Link
US (1) US6063811A (de)
EP (1) EP0910368A1 (de)
JP (1) JPH11512754A (de)
KR (1) KR100373622B1 (de)
CN (1) CN1140267C (de)
AR (1) AR012014A1 (de)
AU (1) AU3004997A (de)
BG (1) BG103000A (de)
BR (1) BR9709097A (de)
CA (1) CA2254061C (de)
CO (1) CO5050370A1 (de)
CZ (1) CZ291463B6 (de)
DZ (1) DZ2200A1 (de)
EA (1) EA001596B1 (de)
EE (1) EE03746B1 (de)
HK (1) HK1021623A1 (de)
HR (1) HRP970262A2 (de)
HU (1) HUP9902889A3 (de)
ID (1) ID16921A (de)
IL (1) IL126899A (de)
IS (1) IS4891A (de)
MY (1) MY116201A (de)
NO (1) NO985342L (de)
NZ (1) NZ332670A (de)
PE (1) PE66998A1 (de)
PL (1) PL188649B1 (de)
SK (1) SK284330B6 (de)
TR (1) TR199802345T2 (de)
WO (1) WO1997044028A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
KR20020082473A (ko) * 1999-12-22 2002-10-31 파마시아 코포레이션 시클로옥시게나제-2 억제제의 지속-방출 조제물
EA200802070A1 (ru) 2000-06-13 2009-06-30 Вайет Болеутоляющее и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
US20020071857A1 (en) * 2000-08-18 2002-06-13 Kararli Tugrul T. Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1423114A4 (de) * 2001-05-04 2006-05-17 Merck & Co Inc Verfahren und zusammensetzungen zur behandlung von migräne
PE20030323A1 (es) * 2001-08-31 2003-05-12 Novartis Ag Composicion farmaceutica
YU34804A (sh) * 2001-09-26 2006-08-17 Pharmacia Corporation Organoleptički prihvatljivi preparati sa oralnim razlaganjem
IL161253A0 (en) * 2001-10-10 2004-09-27 Pharmacia Corp Intraorally disintegrating valdecoxib compositions prepared by spray drying process
TW200305443A (en) * 2002-03-07 2003-11-01 Novartis Ag Pharmaceutical compositions
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
CA2676413A1 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
WO2020106522A1 (en) 2018-11-21 2020-05-28 Tremeau Pharmaceuticals, Inc. Purified forms of rofecoxib, methods of manufacture and use
WO2020210341A1 (en) * 2019-04-09 2020-10-15 Tremeau Pharmaceuticals, Inc. Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal antiinflammatory drugs
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
CN1143365A (zh) * 1994-01-10 1997-02-19 麦克弗罗斯特(加拿大)有限公司 作为cox-2抑制剂的苯基杂环类化合物

Also Published As

Publication number Publication date
CZ291463B6 (cs) 2003-03-12
AR012014A1 (es) 2000-09-27
JPH11512754A (ja) 1999-11-02
CN1225010A (zh) 1999-08-04
PL188649B1 (pl) 2005-03-31
NZ332670A (en) 2000-07-28
TR199802345T2 (xx) 1999-03-22
KR20000011082A (ko) 2000-02-25
IS4891A (is) 1998-11-10
HUP9902889A2 (hu) 2002-01-28
CA2254061C (en) 2003-12-02
NO985342D0 (no) 1998-11-16
NO985342L (no) 1998-11-16
BG103000A (en) 1999-09-30
SK284330B6 (sk) 2005-01-03
KR100373622B1 (ko) 2003-07-12
BR9709097A (pt) 1999-08-03
IL126899A0 (en) 1999-09-22
AU3004997A (en) 1997-12-09
EA199801017A1 (ru) 1999-04-29
CO5050370A1 (es) 2001-06-27
IL126899A (en) 2004-03-28
CA2254061A1 (en) 1997-11-27
CN1140267C (zh) 2004-03-03
EE9800393A (et) 1999-06-15
PL329940A1 (en) 1999-04-26
WO1997044028A1 (en) 1997-11-27
MY116201A (en) 2003-11-28
HUP9902889A3 (en) 2002-04-29
CZ373898A3 (cs) 1999-06-16
HK1021623A1 (en) 2000-06-23
EE03746B1 (et) 2002-06-17
HRP970262A2 (en) 1998-06-30
SK156798A3 (en) 2000-01-18
EP0910368A1 (de) 1999-04-28
US6063811A (en) 2000-05-16
EA001596B1 (ru) 2001-06-25
PE66998A1 (es) 1998-10-24
DZ2200A1 (fr) 2004-06-20

Similar Documents

Publication Publication Date Title
ID16921A (id) Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2
DK0769017T3 (da) Terapeutiske forbindelser
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
DE69618854T2 (de) Fotopolymerisierbare Zusammensetzung
ID18168A (id) Mekanisma pengatur waktu katup bervariasi mesin
DE69520639T2 (de) Desinfizierende Zusammensetzung
BR9605176A (pt) Composição fotocurável
DE69626993D1 (de) Wundbehandlungszusammensetzung
BR9607925A (pt) Composição fungicida
DE69604601T2 (de) Fotopolymerisierbare Zusammensetzung
DE69503738D1 (de) Fotopolymerisierbare Zusammensetzung
DE69505358T2 (de) Gewebeweichmacherzusammensetzung
ID17723A (id) Senyawa untuk pengobatan
EP0944635A4 (de) Therapeutische diphosphonatverbindungen
NO983090D0 (no) Terapeutiske forbindelser
FI971447A0 (fi) Venttiili käsienpesuallasta varten
BR9607487A (pt) Composição herbicida
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
BR9503633A (pt) Composição desinfetante
BR9610382A (pt) Composição de tratamento do cableo
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons
DE69508069D1 (de) Gewebeweichnacherzusammensetzung
DE69605584D1 (de) Fotopolymerisierbare Zusammensetzung
FI972383A (fi) Osteoporoosihoitojaksoon tarkoitettu pakkaus
ID17345A (id) Metode yang disempurnakan untuk mengendalikan rayap